XOMA Royalty Corporation (LON: 0M26)

Market Cap	249.22M
Revenue (ttm)	16.12M
Net Income (ttm)	-26.44M
Shares Out	n/a
EPS (ttm)	-2.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	549
Average Volume	71
Open	27.39
Previous Close	28.30
Day's Range	27.39 - 27.39
52-Week Range	14.91 - 27.78
Beta	0.81
RSI	47.93
Earnings Date	Mar 7, 2025

About XOMA Royalty

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 13
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0M26

Financial Performance

In 2023, XOMA Royalty's revenue was $4.76 million, a decrease of -21.06% compared to the previous year's $6.03 million. Losses were -$46.30 million, 105.1% more than in 2022.

Financial numbers in USD